Page last updated: 2024-08-23

1-deoxynojirimycin and B-Cell Leukemia

1-deoxynojirimycin has been researched along with B-Cell Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dörrie, J; Sapala, K; Zunino, SJ	1

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and B-Cell Leukemia

Article	Year
Interferon-gamma increases the expression of glycosylated CD95 in B-leukemic cells: an inducible model to study the role of glycosylation in CD95-signalling and trafficking. Cytokine, 2002, Apr-21, Volume: 18, Issue:2 Topics: 1-Deoxynojirimycin; Cell Death; Cell Membrane; Enzyme Inhibitors; fas Receptor; Glycoside Hydrolases; Glycosylation; Humans; Indolizines; Interferon-gamma; Leukemia, B-Cell; Models, Biological; Molecular Weight; Neuraminidase; Oligosaccharides; Protein Processing, Post-Translational; Signal Transduction; Swainsonine; Tumor Cells, Cultured; Vibrio cholerae	2002

Article

Year

Interferon-gamma increases the expression of glycosylated CD95 in B-leukemic cells: an inducible model to study the role of glycosylation in CD95-signalling and trafficking.

Cytokine, 2002, Apr-21, Volume: 18, Issue:2

Topics: 1-Deoxynojirimycin; Cell Death; Cell Membrane; Enzyme Inhibitors; fas Receptor; Glycoside Hydrolases; Glycosylation; Humans; Indolizines; Interferon-gamma; Leukemia, B-Cell; Models, Biological; Molecular Weight; Neuraminidase; Oligosaccharides; Protein Processing, Post-Translational; Signal Transduction; Swainsonine; Tumor Cells, Cultured; Vibrio cholerae

2002